Article
Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutation.
Biochemical and biophysical research communications - 4 Nov 2016
Zahavi Tamar, Yahav Gilad, Shimshon Yael, Gershanov Sivan, Kaduri Luna, Sonnenblick Amir, Fixler Dror, Salmon Asher Y, Salmon-Divon Mali
Abstract excerpt
Worldwide, more than one million women are diagnosed with breast cancer every year, making it the most common female malignancy in the developed world. Germline mutations in BRCA1 and BRCA2 genes are estimated to increase the risk for developing breast cancer by up to 87%. From a clinical point of view, identification of BRCA1 and BRCA2 mutation carriers offers an opportunity to early identify or prevent the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.